Inflammation plays a crucial role in the development and progression of bursitis, contributing to its symptoms and clinical manifestations. TheHealthSite.com
Press release content from Newswire. The AP news staff was not involved in its creation.
Stem Cell Recruitment Therapy® Registration Awarded by U.S. Patent & Trademark Office for Russell Health
January 27, 2021 GMT
Stem Cell Recruitment Therapy® by Russell Health
WILLOWBROOK, Ill. - January 26, 2021 - ( Newswire.com )
Based in Willowbrook, Illinois, Russell Health, a national marketer and distributor of specialty medical products and services, has recently been issued company trademark registrations from the United States Patent and Trademark Office.
Russell Health, Inc., a leading regenerative medicine company, announced today the United States Patent and Trademark Office has issued registrations for the company’s trademarks - Stem Cell Recruitment Therapy® (Reg. No. 6,109,514) and Stem Cell Recruitment Facial® (Reg. No. 6,218,705), signifying that the company has met the stringent United States standards for exclusively applying its trademarks to the company’s produ
Share this article
BOSTON, Jan. 8, 2021 /PRNewswire/ Emulate, Inc., a leading provider of advanced in vitro models, today announced an application roadmap for their market leading organ-on-a-chip technology that expands beyond small molecule applications and addresses the growing focus on targeted and advanced biologics within drug development. These new human organ models enable the technology to be used within stages of the drug discovery and development process that are iterative, including, target identification and validation, mechanistic studies, drug delivery and biomarker identification.
Today, biologic drugs comprise 40 percent of the drug development pipeline, a percentage that is expected to continue to grow in the coming years. Biologics are highly specific and tailored to human pathways and targets, often involving complex engagement of immune cells. Current